Notably, all three bivariate AUC maps provided top 10% AUCs above 0.7 for predicting high‐grade prostate cancer, with LALS‐PSMA having an AUC above 0.8 for predicting grade group 5 prostate cancer. This evidence concerns the gene FOLH1 and prostate cancer.